Sue Harnan
School of Medicine and Population Health
Senior Research Fellow
+44 114 222 0869
Full contact details
School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
ºù«Ӱҵ
S1 4DA
- Profile
-
I graduated from the University of ºù«Ӱҵ in 1996 with a BSc in Physiology and went on to graduate with an MSc in Science, Culture and Communication at the University of Bath in 2002. I worked in the charitable sector as a systematic reviewer at Penny Brohn Cancer Care for two years before joining ScHARR in 2009.
My primary interest is in Health Technology Assessment, and I have been a member of ScHARR’s Technology Assessment Group (ScHARR-TAG), which conducts assessments for the National Institute for Health and Care Excellence (NICE), since 2009. I have worked on and led systematic reviews and technology appraisals on a wide range of topics as part of this programme of work, and have special interest and expertise in diagnostic and prognostic topics.
I also plan and conduct reviews as part of ScHARR’s Knowledge Exchange partnerships, with industry, public health and charitable funders.
- Research interests
-
- Health technology assessment
- Systematic review methodologies including
- Diagnostic reviews
- Rapid reviews
- Review of reviews
- Review techniques for network meta analyses
- Non-RCT reviews
- Systematic review of psychometric properties of outcome measures
- Health and wellbeing benefits of the natural environment
Recent and current projects
Recent and current NICE projects
- Quantitative faecal immunochemical tests to guide referral in primary care for people with a change in bowel habit or abdominal pain [DAP50] (Diagnostic Assessment Report for NICE) (2020- ongoing; project lead)
- Volanesorsen for treating familial chylomicronaemia syndrome [ID1326] (Highly Specialised Technology assessment for NICE) (2018-19; project lead)
- Velmanase alfa for treating alpha-mannosidosis [ID800] (Highly Specialised Technology Assessment for NICE) (2018-19) Trifluridine–tipiracil for treating metastatic gastric or gastro-oesophageal junction cancer after 2 or more therapies [ID1507](Single Technology Appraisal for NICE) (2019)
- Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis (Diagnostic Assessment for NICE) (2017-18; project lead)
Recent and current other work
- The impact of pruritus on health-related quality of life (HRQoL) in patients with end-stage kidney disease (ESKD) or chronic kidney disease associated with pruritus (CKD-aP) on haemodialysis: a systematic review (Commercial sponsor) (2020 – ongoing)
- A series of systematic reviews and meta-analyses of the risk of hip and non-vertebral fractures in patients with chronic kidney disease, Parkinson’s disease and diabetes (Commercial Sponsor) (2019)
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
Conference proceedings papers
All publications
Journal articles
Conference proceedings papers
Reports
Posters
- Teaching interests
-
I am a module co-ordinator for HAR6501, Systematic Reviews and Critical Appraisal Techniques on ScHARR’s Masters in Public Health. I also teach on ScHARR’s short courses and bespoke training courses, including our Systematic Review short course, our Rapid Review short course and our short course on Reviewing for Modelling Parameters.